Matarin Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-13,525
| Closed | -$834K | – | 202 |
|
|
2019
Q4 | $834K | Sell |
13,525
-14,107
| -51% | -$870K | 0.08% | 194 |
|
|
2019
Q3 | $2.01M | Sell |
27,632
-112,151
| -80% | -$8.17M | 0.15% | 170 |
|
|
2019
Q2 | $11.5M | Buy |
139,783
+4,384
| +3% | +$360K | 0.82% | 42 |
|
|
2019
Q1 | $9.55M | Buy |
135,399
+12,760
| +10% | +$900K | 0.69% | 59 |
|
|
2018
Q4 | $5.52M | Buy |
122,639
+37,667
| +44% | +$1.7M | 0.45% | 78 |
|
|
2018
Q3 | $4.8M | Buy |
84,972
+11,806
| +16% | +$668K | 0.31% | 109 |
|
|
2018
Q2 | $4.89M | Buy |
73,166
+36,361
| +99% | +$2.43M | 0.35% | 100 |
|
|
2018
Q1 | $2.14M | Buy |
36,805
+23,540
| +177% | +$1.37M | 0.16% | 169 |
|
|
2017
Q4 | $855K | Buy |
13,265
+2,532
| +24% | +$163K | 0.07% | 214 |
|
|
2017
Q3 | $563K | Hold |
10,733
| – | – | 0.05% | 232 |
|
|
2017
Q2 | $502K | Sell |
10,733
-1,350
| -11% | -$63.2K | 0.05% | 221 |
|
|
2017
Q1 | $598K | Buy |
+12,083
| New | +$598K | 0.06% | 216 |
|